Healthy Extracts Inc.

HYEX

US42227D2099

Pharmaceuticals

Delayed OTC Markets Other stock markets 18:31:41 10/04/2024 BST			5-day change	1st Jan Change
2 ^USD	-10.31%		-.--%	-72.22%

05-20	Earnings Flash (HYEX) HEALTHY EXTRACTS Posts Q1 Revenue $688,786	MT
05-20	Healthy Extracts Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Healthy Extracts Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022

August 15, 2022 at 09:59 pm

Healthy Extracts Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.542484 million compared to USD 0.278458 million a year ago. Revenue was USD 0.469812 million compared to USD 0.243886 million a year ago. Net loss was USD 0.859326 million compared to USD 0.557751 million a year ago.
For the six months, sales was USD 1.09 million compared to USD 0.459492 million a year ago. Revenue was USD 0.933198 million compared to USD 0.414318 million a year ago. Net loss was USD 0.856315 million compared to USD 1.85 million a year ago.

Latest news about Healthy Extracts Inc.

Earnings Flash (HYEX) HEALTHY EXTRACTS Posts Q1 Revenue $688,786	05-20	MT
Healthy Extracts Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-20	CI
Healthy Extracts Inc. has withdrawn its IPO in the amount of $10.000001 million.	05-10	CI
Healthy Extracts Inc. cancelled the acquisition of Hyperion, L.L.C. and Online Publishing & Marketing, LLC.	04-17	CI
Healthy Extracts Inc. Provides Revenue Guidance for the First Quarter of 2024	04-01	CI
Healthy Extracts Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
Healthy Extracts Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2023; Provides Revenue Guidance for the First Quarter of 2024	03-13	CI
Healthy Extracts Launches First Anti-Aging Formulation, LONGEVITY	01-04	CI
Healthy Extracts Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Healthy Extracts Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Healthy Extracts Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Healthy Extracts Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23	CI
Healthy Extracts Inc. Auditor Raises 'Going Concern' Doubt	30/03/23	CI
Healthy Extracts Inc. announced that it expects to receive $0.3 million in funding	19/03/23	CI
Healthy Extracts Inc. has filed an IPO in the amount of $9.2 million.	09/02/23	CI
Healthy Extracts Inc. announced that it expects to receive $0.388888 million in funding	23/01/23	CI
Healthy Extracts Inc. entered into an acquisition agreement to acquire Hyperion, L.L.C. and Online Publishing & Marketing, LLC for $4.3 million..	19/01/23	CI
Healthy Extracts Inc’s Whitney Johns Launches Brain Activate ENERGY Gel Packs on WhitneyJohns.com	06/12/22	CI
Earnings Flash (HYEX) HEALTHY EXTRACTS Reports Q3 Revenue $499.7M	09/11/22	MT
Earnings Flash (HYEX) HEALTHY EXTRACTS Posts Q3 EPS $0.00	09/11/22	MT
Earnings Flash (HYEX) HEALTHY EXTRACTS Reports Q3 Revenue $499.7M	09/11/22	MT
Healthy Extracts Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	08/11/22	CI
Healthy Extracts Launches Whitney Johns Citrus Bergamot for Women’S Heart Health and Overall Health Exclusively on Amazon	20/09/22	CI
Healthy Extracts Inc. Provides Revenue Guidance for the Year 2022	16/08/22	CI
Healthy Extracts Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22	CI

Chart Healthy Extracts Inc.

Duration

Period

More charts

Company Profile

Healthy Extracts, Inc. is a platform for acquiring, developing, researching, patenting, marketing, and distributing plant-based nutraceuticals. The Company, through BergaMet NA, LLC and Ultimate Brain Nutrients, LLC markets and sells health supplemental products. Its segments include Health Supplements and Corporate. It develops, manufactures, and distributes bergamot-based products (BPF) in tablet and capsule under BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, BergaMet SPORTSHEART and BergaMet CLINICAL IMMUNE. BPF Bergamet products are distributed in North America that contain Citrus Bergamot SuperFruit. Its BergaMet products are certified organic, vegan friendly, non-GMO and gluten-free. Its UBN develops plant-based health technology neuro-products to improve brain health, including memory, cognition, focus and neuro-energy. Its brain health products are sold under various product labels, including UBN ACTIVATE, UBN RELIEF, and Brain Activate-Gel.

Sector

Pharmaceuticals

Calendar

11/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
HEALTHY EXTRACTS INC.	-72.22%	5.93M
DONG-E-E-JIAO CO.,LTD.	+39.27%	6.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-18.60%	4.33B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.27%	3.22B
TASLY PHARMACEUTICAL GROUP CO., LTD	-15.69%	2.96B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-5.88%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+43.78%	1.92B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-11.89%	1.61B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.67%	1.57B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.39%	1.51B